Nurse Practitioner, Family · Chattanooga, TN
NPI
1003215500
Since 2014
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1726 Gunbarrel Rd Ste 100
Chattanooga, TN, 37421
Phone (423) 954-9010
Groups this clinician bills Medicare through
Medicare paid, 2024
$83K
2,658 services
Medicare patients, 2024
414
Average age 73
Drug cost, 2024
$4.4M
6,618 prescriptions
Company payments, 2025
$2,234
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Misty Gilliland was code 99214 (office e&m - established), 787 times for 407 patients. In total Misty Gilliland billed 2,658 services in 29 codes, and Medicare paid $83K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 787 | 407 | $75.86 | $60K |
| 83036 Blood Count | Office | 688 | 379 | $9.18 | $6,319 |
| 95251 Test - Miscellaneous | Office | 462 | 238 | $20.98 | $9,695 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 150 | 115 | $10.89 | $1,633 |
| 36415 Venipuncture Blood Collection | Office | 129 | 94 | $8.65 | $1,116 |
| 84443 Clinical Chemistry | Office | 89 | 67 | $16.46 | $1,465 |
| 82962 Clinical Chemistry | Office | 72 | 67 | $3.17 | $228 |
| 84439 Clinical Chemistry | Office | 68 | 47 | $8.84 | $601 |
| 80061 Clinical Chemistry | Office | 67 | 55 | $12.96 | $869 |
| 80053 Clinical Chemistry | Office | 53 | 44 | $10.18 | $540 |
| 82043 Clinical Chemistry | Office | 26 | 25 | $5.47 | $142 |
| 82570 Clinical Chemistry | Office | 26 | 25 | $4.91 | $128 |
| 99213 Office E&M - Established | Office | 14 | 14 | $30.33 | $425 |
By year: 2022 $98K for 4,249 services; 2023 $89K for 3,693 services; 2024 $83K for 2,658 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 688 | 379 | $9.18 | $6,319 |
| 36415 Venipuncture Blood Collection | 129 | 94 | $8.65 | $1,116 |
| 84443 Clinical Chemistry | 89 | 67 | $16.46 | $1,465 |
| 82962 Clinical Chemistry | 72 | 67 | $3.17 | $228 |
| 84439 Clinical Chemistry | 68 | 47 | $8.84 | $601 |
| 80061 Clinical Chemistry | 67 | 55 | $12.96 | $869 |
| 80053 Clinical Chemistry | 53 | 44 | $10.18 | $540 |
| 82043 Clinical Chemistry | 26 | 25 | $5.47 | $142 |
| 82570 Clinical Chemistry | 26 | 25 | $4.91 | $128 |
Medicare prescription drug claims, 2024
In 2024, the drug Misty Gilliland prescribed most often to Medicare patients was Ozempic (Semaglutide), with 640 prescriptions and refills. In total Misty Gilliland wrote 6,618 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 640 | 1,050 | 153 | $978K |
| Mounjaro Tirzepatide | 481 | 585 | 117 | $609K |
| Jardiance Empagliflozin | 431 | 868 | 104 | $493K |
| Metformin Hcl Generic | 412 | 1,105 | 116 | $2,719 |
| Novolog Flexpen Insulin Aspart | 385 | 718 | 122 | $153K |
| Tresiba Flextouch U-100 Insulin Degludec | 262 | 603 | 88 | $191K |
| Farxiga Dapagliflozin Propanediol | 255 | 476 | 68 | $260K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 253 | 596 | 72 | $218K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 226 | 488 | 73 | $32K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 183 | 503 | 93 | $27K |
| Rosuvastatin Calcium Generic | 160 | 469 | 56 | $2,627 |
| Metformin Hcl Er Metformin Hcl | 160 | 448 | 51 | $1,859 |
| Novolog Insulin Aspart | 155 | 321 | 47 | $63K |
| Trulicity Dulaglutide | 147 | 209 | 37 | $199K |
| Humalog Kwikpen U-100 Insulin Lispro | 141 | 270 | 46 | $52K |
Brand drugs: 4,332 claims; generic drugs: 1,595 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Misty Gilliland $2,234 ($2,234 in general payments such as food, travel and fees) from 23 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $296.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 20 | $296 |
| Lilly USA, LLC LLY | 22 | $279 |
| Insulet Corporation PODD | 22 | $248 |
| Novo Nordisk Inc NVO | 11 | $226 |
| Abbott Laboratories ABT | 8 | $157 |
| CeQur Corporation | 1 | $149 |
| Dexcom, Inc. DXCM | 5 | $123 |
| Ascendis Pharma Endocrinology Inc ASND | 6 | $119 |
| Sequel Med Tech, LLC | 5 | $100 |
| Medtronic, Inc. MDT | 2 | $89.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.